ANTIGENICS INC.

Company

AGENUS INC

Filed

April 22, 2005

Period of Report

June 1, 2005

Accession Number

0000950135-05-002138

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →